DATA WAIVER – Buprenorphine Waiver Processing and Support

For the Substance Abuse and Mental Health Services Administration (SAMHSA), DSG operates the DATA Waiver Processing and Support contract.

PROJECT OVERVIEW

The work includes 1) maintaining, updating, and improving the Buprenorphine Waiver Notification System (BWNS) and the Buprenorphine Web board; 2) providing support for questions relating to Buprenorphine by telephone or email to physicians, pharmacists, and the general public; 3) maintaining and updating an informational Web site on Buprenorphine, including a physician locator (currently with Project Evolve); 4) monitoring and approving physician discussions on the Buprenorphine Web board; 5) providing ad hoc reporting support to SAMHSA; 6) providing training for SAMHSA; 7) sending announcements to all physicians over a listserv; 8) coordinating and collaborating with the Government Performance Reporting Act contractor to report on outcomes (though the task was never initiated under previous contracts); 9) providing outreach activities to increase the number of physicians who choose to be listed on the locator (neither has this task been initiated under previous contracts); and 10) processing about 3,000 new Notices of Intent Waiver to Prescribe Buprenorphine and treat up to 30 patients, along with about 1,500 second Notices of Intent Waiver to Prescribe Buprenorphine and treat up to a hundred patients.

 

PROJECT TEAM
DSG RESEARCH TEAM
  • Principal Investigator Stephen Gies, Ph.D.
  • Co-Principal Investigator Nicole Piquero, Ph.D., with the University of Texas at Dallas
  • Alex Piquero, Ph.D., with the University of Texas at Dallas
  • Jennifer Grotpeter, Ph.D.
  • Brandn Green, Ph.D.
CONTACT US ABOUT THIS PROJECT

If you have been a victim of identity theft and are in need of services, please visit the website of the ITRC

For More Information About the Identity Theft Study

Contact DSG Senior Research Scientist Stephen Gies at 301.951.0056 or sgies@dsgonline.com

PROJECT MATERIALS
  • REPORT 1
  • REPORT 2
  • PRESENTATION 1
  • PRESENTATION 2